Skip to main content

Table 4 Comparison of lipid data between patients with below- and abovemedian CETP levels

From: Serum CETP status is independently associated with reduction rates in LDL-C in pitavastatin-treated diabetic patients and possible involvement of LXR in its association

 

Patients with CETP levels below the median (<2.6μg/mL; n = 21 )

Patients with CETP levels above the median (≧ 2.6 μg/mL; n = 23 )

p

Baseline CETP (p,g/mL)

2.12 ± 0.3

3.01 ± 0.44

<0.01

Post-treatment CETP (p,g/mL)

1.48 ± 0.36

2.44 ± 0.71

<0.01

Change in CETP (%)

−28.9 ± 20.3

−19.2 ± 17.0

0.09

Baseline LDL-C (mg/dL)

143.5 ± 234.1

157.0 ± 34.9

0.14

Post-treatment LDL-C (mg/dL)

75.1 ± 15.2

103.6 ± 26.3

<0.01

Change in LDL-C (%)

−46.4 ± 11.2

−33.1 ± 13.1

<0.01

Baseline sd LDL-C (mg/dL)

51.8 ± 16.3

51.7 ± 20.6

0.98

Post-treatment sd LDL-C (mg/dL)

23.9 ± 6.5

32.7 ± 12.1

<0.01

Change in LDL-C (%)

−49.6 ± 13.7

−33.5 ± 19.2

<0.01